| Yasotha Rajeswaran, MD | |
|
1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103-6224 | |
| (610) 402-3110 | |
| (610) 402-3112 |
| Full Name | Yasotha Rajeswaran |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 15 Years |
| Location | 1250 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427291590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD455268 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Essen BioScience, a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research, has launched the IncuCyte® S3 live-cell analysis platform for real-time, automated measurements of cell health, proliferation, movement and function directly inside a standard incubator.
Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
Specialists at Fortis Hospitals Mumbai successfully diagnosed and treated a previously undetected pituitary tumor in Michelle Hardin, a 35 year-old American medical traveler.
› Verified 9 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Essen BioScience, a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research, has launched the IncuCyte® S3 live-cell analysis platform for real-time, automated measurements of cell health, proliferation, movement and function directly inside a standard incubator.
Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
Specialists at Fortis Hospitals Mumbai successfully diagnosed and treated a previously undetected pituitary tumor in Michelle Hardin, a 35 year-old American medical traveler.
› Verified 9 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Essen BioScience, a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research, has launched the IncuCyte® S3 live-cell analysis platform for real-time, automated measurements of cell health, proliferation, movement and function directly inside a standard incubator.
Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
Specialists at Fortis Hospitals Mumbai successfully diagnosed and treated a previously undetected pituitary tumor in Michelle Hardin, a 35 year-old American medical traveler.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yasotha Rajeswaran, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Yasotha Rajeswaran, MD 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103-6224 Ph: (610) 402-3110 |
News Archive
Essen BioScience, a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research, has launched the IncuCyte® S3 live-cell analysis platform for real-time, automated measurements of cell health, proliferation, movement and function directly inside a standard incubator.
Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
Specialists at Fortis Hospitals Mumbai successfully diagnosed and treated a previously undetected pituitary tumor in Michelle Hardin, a 35 year-old American medical traveler.
› Verified 9 days ago
Jessica Mary Boehmler, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Muhammad Majeed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5369 | |
Allison Jane Baragona, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 |